Loading...
Loading...

On this episode, we’ll meet Melanie Matheu, Ph.D., a scientist turning light into life. Her company, Prellis Biologics, has developed what may be a defining technology for the bioprinting industry: A method to print biology on the cellular level. They're shipping printed vasculature and organoids now, and have a plan to be in the clinic with printed organs within 3 years; that's right, some day you might walk around with a Prellis Biologics bioprinted organ inside you. Another interesting startup with huge potential. This is the TomorrowScale Podcast. Hosted by Justin Briggs.
The TomorrowScale Podcast was created by Justin Briggs to showcase technology companies building the future. Interviews may be with old friends or were cold-contacted by Justin directly to be on the show. The views expressed by the host and guests are their own, and the content of this show should not be considered legal, tax, or investing advice. Thank you to our guests for sharing their time and knowledge with us. And thank you for listening. Please science responsibly.
Visit us at http://TomorrowScale.com
No transcript available for this episode.